Narrative Review of the Pathogenesis of Stasis Dermatitis: An Inflammatory Skin Manifestation of Venous Hypertension

Abstract

Introduction Stasis dermatitis (SD), also known as venous dermatitis, is a form of inflammatory dermatitis of the lower extremities that typically occurs in older individuals and represents a cutaneous manifestation of venous hypertension. Venous hypertension (also known as sustained ambulatory venous pressure) is most often due to retrograde blood flow, which occurs due to calf muscle pump failure. This failure is most commonly secondary to incompetent venous valves, valve destruction, or obstruction of the venous system. Many of the common symptoms associated with SD are caused by inflammatory processes. Methods This review summarizes the pathogenesis and key role of inflammation in SD by reviewing inflammatory biomarkers associated with SD. The literature was selected though a high-level PubMed search focusing on keywords relating to inflammation associated with SD. Results Venous reflux at the lower extremities causes venous hypertension, which leads to chronic venous insufficiency. High venous pressure due to venous hypertension promotes the local accumulation and extravasation of inflammatory cells across the vascular endothelium. Leukocyte trapping in the microcirculation and perivascular space is associated with trophic skin changes. Cell adhesion molecules are linked with the perpetuated influx of activated leukocytes into inflammatory sites. Here, inflammatory cells may influence the remodeling of the extracellular matrix by inducing the secretion of proteinases such as matrix metalloproteinases (MMPs). The increased expression of MMPs is associated with the formation of venous leg ulcers and lesions. Phosphodiesterase 4 activity has also been shown to be elevated in individuals with inflammatory dermatoses compared to healthy individuals. Discussion Because inflammation is a key driver of the signs and symptoms of SD, several of the highlighted biomarkers of inflammation represent potential opportunities to target and interrupt molecular pathways of cutaneous inflammation and, therefore, remediate the signs and symptoms of SD. Conclusion Understanding the pathogenesis of SD may help clinicians identify drivers of inflammation to use as potential targets for the development of new treatment options.

Some new aspects of the pathogenesis of venous trophic ulcers

“…Выделяющиеся из активированных лейкоцитов цитокины, лейкотриены, простагландины, протеолитические ферменты, факторы активации тромбоцитов, а также свободные радикалы кислорода приводят к развитию и прогрессированию хронического воспаления с нарушением барьерной функции кожи, что сопровождается массивным экссудативным процессом с некрозом мягких тканей. Впоследствии происходит быстрая бактериальная контаминация, прогрессирование воспаления, развитие индуративного целлюлита, дерматита и в итоге формирование ТЯ [34][35][36][37]. Поддержание высокого уровня ПМЯЛ приводит к избыточному высвобождению ими протеаз, таких как эластаза нейтрофилов человека, которые в конечном счете разрушают новообразованную ткань, факторы роста, рецепторы и внеклеточный матрикс, которые необходимы для заживления.…”

Effect of Trendelenburg’s Operation With Subfascial Ligation of Perforators in Clinical Improvement and Quality of Life Among Patients With Varicose Veins

“…Physician-driven tools are based on their observations, classifying the disease, and evaluating clinically relevant changes over time. A revised venous clinical severity score (rVCSS) documents and evaluates CVD progression [ 13 , 14 ]. Chronic venous insufficiency quality of life questionnaire (CIVIQ)-14 score is widely used to assess disease-specific QoL in CVD [ 15 , 16 ].…”